These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 21110142)

  • 21. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
    Rizzi PM; Ryder SD; Portmann B; Ramage JK; Naoumov NV; Williams R
    Gut; 1996 Feb; 38(2):265-8. PubMed ID: 8801209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
    Boberg KM; Schrumpf E; Bergquist A; Broomé U; Pares A; Remotti H; Schjölberg A; Spurkland A; Clausen OP
    J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathology of cholangiocarcinoma].
    Guedj N; Bedossa P; Paradis V
    Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "De novo" cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!
    Bourdeleau P; Larrey E; Allaire M; Charlotte F; Vaillant JC; Lebray P
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101827. PubMed ID: 34740844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.
    Charbel H; Al-Kawas FH
    Curr Gastroenterol Rep; 2011 Apr; 13(2):182-7. PubMed ID: 21271364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning.
    Masselli G; Gualdi G
    Abdom Imaging; 2008; 33(4):444-51. PubMed ID: 17638040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
    de Groen PC
    Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
    Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
    Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
    Walker SL; McCormick PA
    Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1].
    Guettier C
    Ann Pathol; 2014 Aug; 34(4):309-14. PubMed ID: 25132442
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free survival.
    Gringeri E; Bassi D; D'Amico FE; Boetto R; Polacco M; Lodo E; D'Amico F; Vitale A; Boccagni P; Zanus G; Cillo U
    Transplant Proc; 2011 May; 43(4):1187-9. PubMed ID: 21620084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis.
    Kanemitsu E; Esaki M
    Jpn J Clin Oncol; 2010 Jun; 40(6):600. PubMed ID: 20508074
    [No Abstract]   [Full Text] [Related]  

  • 37. Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration.
    Sato H; Nakanuma Y; Kozaka K; Sato Y; Ikeda H
    Int J Clin Exp Pathol; 2013; 6(2):318-22. PubMed ID: 23330019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
    Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
    Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9.
    Rogers SA; Podolsky DK
    Hepatology; 1994 Feb; 19(2):543-5. PubMed ID: 8294114
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: finding a needle in a haystack.
    Navaneethan U
    Endoscopy; 2016 May; 48(5):417-8. PubMed ID: 27115919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.